A new, theoretically safer method of intravitreal injection of bevacizumab in progressive retinopathy of prematurity using scleral trans-illumination.
Patel
C K
CK
Walker
N J
NJ
Kam
J K
JK
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D056965:Injections, Intraocular; D008029:Lighting / Q000379:methods*; D012178:Retinopathy of Prematurity / Q000188:drug therapy*; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab